Adolescents with Cannabis Hyperemesis Also Developed Dangerously Low Phosphorus

Three adolescents with cannabinoid hyperemesis syndrome developed recurrent hypophosphatemia, a potentially serious electrolyte abnormality that complicated their clinical course.

Nachnani, Rahul et al.·JPGN reports·2022·Preliminary EvidenceCase Report
RTHC-04092Case ReportPreliminary Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Three adolescents with CHS developed recurrent hypophosphatemia (low phosphorus) that complicated their hospitalizations. The authors highlight that providers should consider CHS in vomiting adolescents and monitor electrolytes closely, as hypophosphatemia can cause serious complications.

Key Numbers

3 adolescents; recurrent hypophosphatemia in all cases; CHS diagnosis

How They Did This

Case series of 3 adolescents presenting with cannabinoid hyperemesis syndrome and recurrent hypophosphatemia, with clinical details of each case.

Why This Research Matters

Hypophosphatemia can cause muscle weakness, respiratory failure, cardiac dysfunction, and seizures. Recognizing this complication in adolescents with CHS ensures appropriate monitoring and treatment.

The Bigger Picture

As CHS becomes more common in adolescents, clinicians need to be aware of electrolyte complications beyond the typical nausea and vomiting presentation. Hypophosphatemia adds another dimension of risk.

What This Study Doesn't Tell Us

Only 3 cases. Cannot determine how common hypophosphatemia is in CHS or whether it is specific to adolescents.

Questions This Raises

  • ?How common is hypophosphatemia in CHS presentations?
  • ?Is the mechanism related to vomiting-induced losses, refeeding, or a direct cannabinoid effect on phosphorus metabolism?

Trust & Context

Key Stat:
Recurrent hypophosphatemia in all 3 adolescent CHS cases
Evidence Grade:
Three-case series providing clinical awareness but cannot establish prevalence or mechanisms.
Study Age:
Published in 2022
Original Title:
Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Adolescents.
Published In:
JPGN reports, 3(4), e248 (2022)
Database ID:
RTHC-04092

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

Can cannabinoid hyperemesis cause electrolyte problems?

This case series found 3 adolescents with CHS developed recurrent hypophosphatemia (low phosphorus), which can cause muscle weakness, respiratory problems, and cardiac issues if untreated.

What should doctors watch for in adolescent CHS?

Beyond managing nausea and vomiting, the authors recommend monitoring serum electrolytes closely, particularly phosphorus, as recurrent hypophosphatemia complicated the clinical course in all three cases.

Read More on RethinkTHC

Cite This Study

RTHC-04092·https://rethinkthc.com/research/RTHC-04092

APA

Nachnani, Rahul; Hushagen, Kimberly; Swaffield, Thomas; Jhaveri, Punit; Vrana, Kent E; Alexander, Chandran P. (2022). Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Adolescents.. JPGN reports, 3(4), e248. https://doi.org/10.1097/PG9.0000000000000248

MLA

Nachnani, Rahul, et al. "Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Adolescents.." JPGN reports, 2022. https://doi.org/10.1097/PG9.0000000000000248

RethinkTHC

RethinkTHC Research Database. "Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Ado..." RTHC-04092. Retrieved from https://rethinkthc.com/research/nachnani-2022-cannabinoid-hyperemesis-syndrome-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.